Biosafety Cabinet Market to exceed US$ 429.47 million by 2028

    Published on 26-Apr-2023
         Request For Sample

    Report : Biosafety Cabinet Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products Handled (Biological Products and Toxic Products), Category (Work Trays, Side Panel Construction, and Accessories), Type (Class I Biosafety Cabinet, Class II Type A2 and Class II Type B1, Class II Type B2 Biosafety Cabinet, Class II Biosafety Cabinet, Customized Cabinets, and Others), Application (Medical Health, Disease Prevention, Food Safety, Biological Pharmacy, Environment Monitoring, and Others), and End User (Academic Centers, Biotech and Pharmaceutical Companies, Microbiology Centers, Research and Development Centers, Hospitals and Clinics, Diagnostic Laboratories, and Others)

    In 2022, Class II Type A2 and Class II Type B1 Segment, by Type, Held Largest Share of Biosafety Cabinet Market

    According to our latest study on "Biosafety Cabinet Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Products Handled, Category, Type, Application, and End User," the market is expected to grow from US$ 276.88 million in 2022 to US$ 429.47 million by 2028; it is estimated to register a CAGR of 7.6% during 2023–2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.

    Biosafety cabinets are efficient devices used to control contamination in laboratories dealing with infectious agents. These act as a primary barrier for restricting the escape of biological aerosols in the lab environment. The biosafety cabinets are broadly classified in three types —class I cabinets, class II cabinets, and class III cabinets. Specific regulations and guidelines imposed by the medical ruling authorities in each region recommend the use of the appropriate type of cabinets to carry out protocols based on the levels of risk involved. Rising prevalence of infectious diseases and rising strategic initiatives are among the factors contributing to the growing biosafety cabinet market size. Moreover, biosafety cabinet market size is likely to surge by 2028 owing to rapid developments in pharmaceutical and biotechnology research to provide lucrative opportunity.

    Infectious diseases are rapidly increasing across the world. The World Health Organization reported that infectious diseases are likely to cause over 30 million deaths each year. According to a new report by TB facts Org, ~10.6 million people were diagnosed with tuberculosis (TB) in 2021, which has increased by 4.5% from 10.1 million in 2020 globally. Additionally, the ease of international travel has led to an additional layer of complexity in terms of tackling with the infectious diseases. Moreover, changing climatic conditions on a global level have contributed to the prevalence of infectious diseases as it can increase the severity of the infectious diseases. As per United Nations Office for Disaster Risk Reduction (UNDDR), climate change can intensify the infectious diseases encountered by humans on global level by 58%. 
    Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola virus disease, chikungunya, avian flu, swine flu, zika virus infection, and most recently, COVID-19. As per CDC, between September 2020 and May 2021, 1,675 of 818,939 respiratory specimens tested by US clinical laboratories were positive for an influenza virus in the US. Antibiotic techniques such as vaccinations against influenza help reduce the illness by 17% and medical visits and hospitalizations by 18% and 19%, respectively. Patient samples are collected to conduct a vast number of experiments and studies for formulating anti-dotes and vaccines to curb infectious diseases. Additionally, appropriate care and management of these samples require a suitable workstation and sanitized environment. These controlled and disinfected environments are mostly possible with the use of biological safety cabinets, which propels the growth of the biosafety cabinet market.

    Based on type, the biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 and class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 and class II type B1 segment accounted for the largest market share in 2022. Moreover, the same segment is expected to register the highest CAGR of the biosafety cabinet market during the forecast period. Class II biosafety cabinet protects the user, environment, and biological products. Type A2 biosafety cabinets are equipped with HEPA-filtered downflow. It recirculates 70% of the air within the cabinet, and 30% of the HEPA-filtered air is exhausted either outside the atmosphere with a thimble duct connection or back in the laboratory. In the exhaust system, the type A2 biosafety cabinets are hard-ducted and incorporate a negative pressure plenum. These types are widely used for biopharmaceutical, bioproduction, and applied research applications. 

    NuAire Inc, Labconco Corp, Esco Group of Companies, Biobase Biodusty Co Ltd, Thermo Fisher Scientific Inc, IMSET, Heal Force Bio-Meditech Holdings Ltd, Kewaunee Scientific Corp, ACMAS Technologies, and Haier Biomedical are among the key players operating in the biosafety cabinet market.

    The report segments the biosafety cabinet market as follows:

    The global biosafety cabinet market is segmented on the basis of products handled, category, type, application, and end user. Based on products handled, the market is bifurcated into biological products and toxic products. Based on category, the market is segmented into work trays, side panel construction, and accessories. Based on type, the market is segmented into class I biosafety cabinet, class II type A2 and class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. Based on application, the global biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. Based on end user, the market is segmented into academic centers, biotech and pharmaceutical companies, microbiology centers, research and development centers, hospitals and clinics, diagnostic laboratories, and others.

    Based on geography, the biosafety cabinet market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East (the UAE, Saudi Arabia, Kuwait, Egypt, and the Rest of Middle East), Africa (South Africa, Nigeria, Kenya, and the Rest of Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). 
     

    Contact Us
    Contact Person: Sameer Joshi
    Phone: +1-646-491-9876
    Email Id: sales@premiummarketinsights.com

    Get Free Sample PDF

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Have a Question?


    Recent Posts